Fingerprint
Dive into the research topics of 'Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Prema Robinson, Rafael Coveñas, Miguel Muñoz
Research output: Contribution to journal › Review article › peer-review
9
Scopus
citations